의료진 소개
유병철
[
소화기내과,
간센터,
소화기병센터(내시경실),
이식클리닉
]
간암, 간경변증, 간염
외래진료 외래진료
특수클리닉 특수클리닉
진료일정
04
| 날짜 |
|---|
| 오전 |
| 오후 |
논문
논문
- Yoo BC. Tenofovir Alafenamide for Multiple Drug-Resistant Chronic Hepatitis B: A 3-Year Clinical Trial. Clinical Gastroenterology and Hepatology. 2023 Nov;21(12):3185-7.
- Kim JW, Choi WH, Kwon SY, Yoo BC, Kim JH. MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis. Medicina. 2023 Mar;59(3):592.
- Kim JH, Choi WH, Kwon SY, Yoo BC, Kim JH. Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers. Antimicrobial Agents and Chemotherapy. 2022 Aug;66(8):e0027522.
- Yoo BC, Kwon SY. Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching from Tenofovir Disoproxil Fumarate. Clinical Gastroenterology and Hepatology. 2022 Feb;20(2):423-37.
- Kwon BS, Choi WH, Kwon SY, Yoo BC, Park SJ, Kim JH. Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma. Korean Journal of Internal Medicine. 2021 Mar;36(2):292-304.
- Suh JW, Kwon BS, Lee TS, Kwon SY, Choi WH, Yoo BC, Shim CS, Yoon JM, Lee JH, Cheon YK. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma. Korean Journal of Internal Medicine. 2020 May;35(3):566-73.
- Lim YS, Gwak GY, Choi J, Lee YS, Byun KS, Kim YJ, Yoo BC, Kwon SY, Lee HC. Monotherapy with Tenofovir Disoproxil Fumarate for Adefovir-Resistant vs. Entecavir-Resistant Chronic Hepatitis B: a 5-Year clinical trial. Journal of Hepatology. 2019 Jul;71(1):35-44.
- Kim AR, Park E, Kwon SY, Park SJ, Kim YJ, Yoo BC, Choe WH, Kim JH, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment. Korean Journal of Gastroenterology. 2019 Mar;73(3):167-176.
- A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment.. Gut. 2016 Jun;65(6) :1042-51.
- A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naive chronic hepatitis B patients. Hepatol Int. 2014 : 375-381.
- A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment. Hepatol Int. 2013 : 106-110.
- A comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B: results after 2 years of treatment.. Hepatogastroenterology. 2013 : 328-332.
- Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway. World J Gastroenterol. 2012 : 679-684 .
- The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. Hepatogastroenterology. 2011 : 522-528 .
- Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int. 2011 : 722-729.
- Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy. J Gastroenterol. 2011 : 410-414 .
- Clinical significance of core gene mutations during the course of genotype C chronic hepatitis B virus infection. Hepatogastroenterology. 2011 : 1643-1647 .
- The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. Hepatol Int. 2011 : 664-670.